Decentralized Clinical Trial Company: 2026 Buyer’s Guide

Decentralized clinical trials bring the study to patients, not the other way around. If you are evaluating a decentralized clinical trial company, this guide breaks down every moving part in plain language, from recruitment and eConsent to cold chain and risk oversight. You will also find a practical vendor list and a simple way to assess who fits your protocol. Throughout, real numbers and examples keep it grounded.

A quick note on facts that matter right now

In a large survey, 91 percent of researchers saw better retention when mobile nurses and home visits were used
Electronic diaries have shown 94 percent real compliance compared to 11 percent with paper
Over 50 percent of recruitment strategies now leverage electronic health records
Medicare reimbursements for remote patient monitoring rose by more than 3,300 percent from 2019 to 2023
The decentralized trials market is projected to grow about 7.6 percent annually through 2033
About 80 percent of studies miss planned enrollment timelines and average attrition hovers near 30 percent

If you want an integrated software and services partner, explore Curebase’s decentralized clinical trials. The company combines an AI‑native eClinical platform with virtual and community‑based site operations.

What a decentralized clinical trial company does

A modern decentralized clinical trial company provides two things that work together

Software that unifies eConsent, ePRO and eCOA, scheduling, telehealth, integrated EDC, engagement, and analytics
Execution services that extend site operations into homes, community clinics, and retail partners with recruitment, pre screening, in home procedures, and logistics

The best partner should feel like one coordinated engine across technology and people.

A practical decentralized clinical trial company list

Use this shortlist as a starting point. Capabilities vary, so verify specifics for your study

Curebase
Science 37
Medable
THREAD
Lightship
ObvioHealth
Castor
Medidata
Veeva
uMotif
IQVIA
ICON
Labcorp
PCM Trials
Retail and community collaborators such as Walgreens trial services

For an integrated option that blends AI powered eClinical software with nationwide execution, see Curebase.

How to assess the vendor landscape

When you compare one decentralized clinical trial company to another, check

Coverage of core software modules in one login
Proof that software is validated and compliant with 21 CFR Part 11
Ability to run virtual and hybrid sites at scale across your required states or countries
Recruiting power across digital, EHR, and community channels
Field operations such as in home nursing, mobile phlebotomy, pharmacy or retail partners
Cold chain and direct to patient shipping playbooks
Data security posture and interoperability with labs and EHR
Oversight, analytics, and risk based monitoring framework
References and published case metrics

Helpful signals from public case stories

Curebase has supported roughly 30 decentralized diagnostic studies between 2020 and late 2022 and consented more than 10,000 patients
A Curebase supported model enrolled more than 500 patients in one month for a diagnostics study
Retail collaboration examples include Walgreens with in pharmacy blood draws and community prescreening

You can request a capabilities briefing from Curebase if you want a single partner for both eClinical software and field execution.

Patient recruitment

Clinical trial patient recruitment is still the biggest bottleneck. About 80 percent of studies miss enrollment timelines and only a fraction of eligible patients ever hear about a trial. Strong decentralized partners combine

Digital advertising and social outreach with instant prescreen flows
EHR mining through health system or data partners
Community activation with retail clinics and local practices
Physician referral workflows that keep the patient’s doctor engaged

Virtual tactics helped lift enrollment by around 25 percent during the pandemic. Only 3 to 5 percent of US cancer patients enroll in trials, which is why community reach matters.

Pre screening

Pre screening filters for obvious fit before formal screening. Expect

Mobile friendly questionnaires and chatbot style flows
Optional EHR queries with patient authorization
Rapid routing to telehealth screening or a nearby partner clinic
Metrics such as pre screen to enroll ratio and screen fail reasons

Patient retention

Completion is as important as enrollment. Average trial attrition sits near 30 percent. What reliably moves the needle

In home visits, where 91 percent of researchers reported improved retention
Clear scheduling reminders and two way communication
Ride support and flexible visit windows
Device enabled diaries and coaching nudges

ePRO, eCOA, and eConsent platform

Electronic, patient facing workflows should live in one app

ePRO and eCOA capture data with timestamps and branching logic
eConsent uses multimedia and comprehension checks, then records audit trails and version control
Studies show electronic diaries generate 94 percent true compliance versus 11 percent with paper
The eConsent market is projected to reach about 909 million dollars by 2030 at roughly 11 percent annual growth

Curebase provides an integrated participant app and web portal that unifies eConsent, ePRO and eCOA, scheduling, telehealth, and compensation in one place. See a tour at Curebase.

Telehealth or virtual visit

Telehealth keeps follow ups and many assessments remote. A decentralized clinical trial company should support

Secure video visits with note capture into EDC
State licensure coverage plans for investigators
Remote AE assessment and PI oversight
Simple device set up calls and practice sessions for patients

Remote patient monitoring

Remote patient monitoring turns episodic visits into continuous data

Devices include Bluetooth blood pressure cuffs, glucometers, oximeters, patches, and certain wearables
Medicare reimbursement data shows remote monitoring surged by more than 3,300 percent from 2019 to 2023
Physician acceptance of digital health rose from 87 to 95 percent between 2016 and 2022

Define alert thresholds, device provisioning, and data flows into the EDC up front.

Wearable integration

Wearables can capture activity, heart rhythm, sleep, and more

Use FDA cleared or validated devices when possible
Pre specify how raw streams become endpoints such as daily step average or time in range
Plan for missing data, charging, and replacement devices

Connected device integration

Make sure patient devices talk directly to your data systems

Bluetooth and cellular devices should send readings without manual entry
Alerts notify teams if values are out of range or data stops flowing
Interoperability with the eClinical platform avoids duplicate work

Direct data capture

Capture data at the source so it lands in the database once and correctly

Site tablets for eSource
Patient entries through ePRO
Direct feeds from devices and some EHR elements
Strong audit trails and validation to meet Part 11

Home healthcare service and in home nursing

Bring the visit to the patient

Mobile nurses and phlebotomists perform blood draws, vitals, exams, training, and some drug administrations
Delegation and PI oversight keep GCP intact
Clear emergency plans, supplies, and documentation are required

Most sponsors report higher adherence and fewer missed procedures when in home support is available.

At home sample collection and mobile laboratory

At home kits or mobile phlebotomy remove travel burden

Blood, saliva, stool, and urine can be collected at home
Mobile staff may centrifuge samples on site, pack them with stabilizers, and ship the same day
Chain of custody, temperature control, and SOPs mirror site standards

Direct to patient drug delivery

Shipping study drug directly to participants is now common

Central or specialty pharmacies prepare labeled kits and arrange tracked courier delivery
Careful counseling ensures correct use and accountability
For temperature sensitive products, direct to patient overlaps with cold chain plans

Cold chain logistics

Many investigational products and samples require strict temperatures

Typical ranges include 2 to 8 C for refrigerated and below minus 70 C for certain vaccines
Nearly half of products in development are temperature sensitive
Smart shippers and data loggers reduce excursions and waste

Ultra cold distribution for mRNA vaccines proved the value of GPS enabled thermal sensors. Your decentralized clinical trial company should already be fluent here.

Smart packaging

Packaging can do more than protect a bottle

Time temperature indicators or sensors show if a range was exceeded
RFID or NFC tags improve inventory control and authentication
Electronic pill caps and smart blisters record openings to measure adherence and can trigger reminders

Real time shipment tracking

Live tracking increases supply chain visibility and protects data integrity

GPS and temperature sensors track location and condition
Alerts enable rapid resupply or rerouting if delays occur
Patients can receive delivery notifications so someone is home to sign and store as instructed

Packaging and labeling

Correct labels and kit design keep patients safe and trials blinded

Include protocol codes, patient or kit IDs, dose instructions, batch or lot, and expiry
Use clear patient friendly instructions for direct to patient shipments
Labels for blinded trials avoid revealing assignment
US labels include the statement for investigational use

Scheduling reminders

Small nudges and patient engagement create big gains in adherence

Text, email, app push, and calendar invites reduce no shows
Two way options let patients confirm or request a change
For diaries and dosing, time based nudges keep data on schedule

Risk based monitoring

Monitor what matters most, not everything equally

Centralized analytics flag outliers, protocol risk, and data drift
Reduced source data verification focuses on critical fields
Triggered visits and remote review close the loop quickly

Study start up

The right decentralized clinical trial company compresses start up by removing site by site friction

Central IRB use
Remote site initiation
Pre configured workflows for diagnostics and digital therapeutics
Integrated recruiting and virtual site staff

Curebase has public reports of start up timelines in the eight to twelve week range for certain diagnostics programs, which is a fraction of traditional schedules. Ask for recent examples at Curebase.

Data security and interoperability

Security and data flow are non negotiable

Encryption at rest and in transit, two factor authentication, role based access
Documented validation and regular penetration testing
Interoperability with EHR and lab systems using modern standards
In 2022 hundreds of healthcare breaches were reported with multi million dollar impacts, so diligence here is essential
Sponsors have been integrating eConsent with EDC and randomization systems, with one report citing 28 percent already linked

Regulatory compliance, GCP, HIPAA, GDPR

Digital does not lower the bar

GCP applies to decentralized processes exactly as at sites
HIPAA and GDPR drive privacy, purpose limitation, and secure transfer
Electronic records and signatures must meet Part 11 with audit trails
Telemedicine must follow state licensure and prescribing rules
Good distribution practice and good manufacturing practice extend to direct to patient supply

Hybrid trial model

Most studies benefit from a blend of site and remote

Complex procedures and imaging remain in person
Questionnaires, counseling, many safety checks, and routine labs can be remote or near home
Hybrid design widens access and typically improves retention
Community partners and retail clinics extend footprint without opening dozens of traditional sites

Putting it together with one decentralized clinical trial company

A strong partner weaves these parts into one study experience

Unified participant app for consent, diaries, messages, scheduling, telehealth, compensation
Integrated EDC and dashboards for sites, CROs, and sponsors
Recruitment and prescreen at scale
In home and near home procedures
Cold chain and direct to patient logistics
Central monitoring, alerts, and oversight in real time

If you want these building blocks in a single stack, take a look at Curebase. The platform and Omnisite model are built to enroll anywhere, capture clean data continuously, and keep participants engaged.

FAQ

What is a decentralized clinical trial company

A decentralized clinical trial company provides software and services that let studies run outside the four walls of a traditional site. Expect eConsent and ePRO, telehealth, integrated EDC, at home procedures, logistics, and central oversight in one coordinated model.

How do I choose between vendors

Compare end to end coverage, compliance maturity, recruiting strength, in home reach, cold chain and direct shipping playbooks, interoperability, and real study metrics. Ask for validation documents and recent audit outcomes.

Can decentralized models really improve retention

Yes. In a large industry survey, 91 percent of researchers reported higher retention when mobile nurses and home visits were used. Clear scheduling reminders, ride support, and flexible visits add further lift.

What about sensitive drugs and cold shipping

A capable decentralized clinical trial company will manage temperature control with smart shippers and data loggers, maintain chain of custody, and include sensors and real time alerts for direct to patient shipments.

Do regulators accept remote data and eConsent

Regulators have long accepted electronic source, ePRO, and eConsent when Part 11 and GCP requirements are met. Many approvals already include ePRO endpoints. The key is validation, audit trails, and consistent methods.

How fast can we start

With pre configured workflows and central IRB use, some programs reach first patient in within eight to twelve weeks. Timeline depends on protocol complexity, investigational product readiness, and regulatory path.

Where do wearables and remote monitoring fit

They provide continuous safety and efficacy data between visits. Use validated devices, define alert thresholds, and integrate streams into the EDC with clear endpoint definitions.

Who sets up home visits and sample collection

Your decentralized clinical trial company coordinates in home nurses and mobile phlebotomy, provides training and supplies, and ensures documentation and PI oversight. For community options, retail partners can host simple procedures.

If you want a single partner that handles all of the above, you can start a conversation with Curebase.